Leader (L) and L* proteins of Theiler's murine encephalomyelitis virus (TMEV) and their regulation of the virus' biological activities

By M. Takano-Maruyama, Y. Ohara, K. Asakura, T. Okuwa. Journal of Neuroinflammation, 2006

1,013 citations recorded by the source corpus.

Theiler's murine encephalomyelitis virus (TMEV) is divided into two subgroups on the basis of their different biological activities. GDVII subgroup strains produce fatal poliomyelitis in mice without virus persistence or demyelination. In contrast, TO subgroup strains induce demyelinating disease with virus persistence in the spinal cords of weanling mice. Two proteins, whose open reading frames are located in the N-terminus of the polyprotein, recently have been reported to be important for TMEV biological activities. One is leader (L) protein and is processed from the most N-terminus of the polyprotein; its function is still unknown. Although the homology of capsid proteins between DA (a representative strain of TO subgroup) and GDVII strains is over 94% at the amino acid level, that of L shows only 85%. Therefore, L is thought to be a key protein for the subgroup-specific biological activities of TMEV. Various studies have demonstrated that L plays important roles in the escape of virus from host immune defenses in the early stage of infection. The second protein is a 17–18 kDa protein, L*, which is synthesized out-of-frame with the polyprotein. Only TO subgroup strains produce L* since GDVII subgroup strains have an ACG rather than AUG at the initiation site and therefore do not synthesize L*. 'Loss and gain of function' experiments demonstrate that L* is essential for virus growth in macrophages, a target cell for TMEV persistence. L* also has been demonstrated to be necessary for TMEV persistence and demyelination. Further analysis of L and L* will help elucidate the pathomechanism(s) of TMEV-induced demyelinating disease.

View Paper: https://www.semanticscholar.org/paper/b838944f47b230d30a6b99bb15aabf2d258e933a

Citations in the corpus

• Microglial Activation & Chronic Neurodegeneration (2010, unknown): “diators, which accumulate to levels that are harmful to neurons, and often in combination leads to neurodegeneration.(94,98,99) Pioneering work by McGeer et al.”
• Inflammatory Cytokines in Depression: Neurobiological Mechanisms and Therapeutic Implications (2013, unknown): “[PubMed: 15728187] Zhu CB, Lindler KM, Owens AW, Daws LC, Blakely RD, Hewlett WA. Interleukin-1 receptor activation by systemic lipopolysaccharide induces behavioral despair linked to MAPK regulation of CNS serotonin transporters.”
• Microglia: new roles for the synaptic stripper. (2013, unknown): “Rise in TNF-a is a hallmark of acute and chronic neuroinflammation as well as various neuropathological developments including ischemic stroke, Alzheimer’s and Parkinson’s diseases, amyotrophic lateral sclerosis, and multiple sclerosis (McCoy and Tansey, 2008).”
• Inflammatory Cytokines in Experimental and Human Stroke (2012, unknown): “This mechanism is called trans-signaling and contributes to explain that IL-6 has numerous effects in many different cell types, despite the limited expression of the IL-6R (Scheller and Rose-John, 2006).”
• Frontiers in Synaptic Neuroscience Synaptic Neuroscience (unknown): “This work also suggests that in diseases that affect glial cells, pathogenesis may arise through feedback to synapses via this synaptic scaling mechanism (McCoy and Tansey, 2008).”
• ER stress-induced cell death mechanisms. (2013, unknown): “For instance, both spliced XBP-1 and phosphorylated IRE1α were found in the brains of individuals with Alzheimer's disease [67,68].”
• Interrelation of Oxidative Stress and Inflammation in Neurodegenerative Disease: Role of TNF (2015, unknown): “Whereas TNFR1 is predominantly associated with inflammation and neurodegeneration, TNFR2 is involved in tissue regeneration and neuroprotection [14].”
• Immune Influence on Adult Neural Stem Cell Regulation and Function (2009, unknown): “In the brain, TNF-a has the paradoxical ability to both protect and destroy neurons (McCoy and Tansey, 2008).”
• TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. (2014, unknown): “What is clear is that cytokines such as TNF, IL-1 and IFNg are produced by glial cells in the CNS, but whether TNF plays a protective or pathological role appears to depend highly on the context (for reviews see [153,154]).”
• Neuronal Cell Death. (2018, unknown): “Proinflammatory cytokines such as IL-1 and TNF- can induce neuronal cell death in culture and in vivo (253, 459), but in general, this is indirect toxicity mediated by activation of glia (498, 669).”
• AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan (2011, unknown): “ER stress can generate an inflammatory response via different signaling pathways [10, 13, 14].”
• The Central Nervous System and the Gut Microbiome (2016, unknown): “Proinflammatory cytokines produced both in the brain and periphery modulate neuronal function and can initiate pathologic cell death (Koprich et al., 2008; McCoy and Tansey, 2008).”
• Mechanisms Underlying Inflammation in Neurodegeneration (2010, unknown): “Proinflammatory cytokines, such as TNF-a, IL-1b, and IL-6, might act directly on neurons to induce apoptosis (McCoy and Tansey, 2008; Simi et al., 2007).”